Evidence map›Paper›PMID 41727408›Full record

ArticleToxicology reports2026

Lack of genotoxicity and subchronic toxicity in safety assessment studies of a

Esther J Yu, John Eid, Jaime Hernandez-Maldonado, Andrew Cheng, Tara Kurihara, Jason L Blum, Denise DiCarlo Emery, Barry Lynch

Abstract read
In one paragraph

Article in Toxicology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Esther J YuPendulum Therapeutics, Inc., 2001 Bryant Street, San Francisco, CA 94110, USA.
John EidPendulum Therapeutics, Inc., 2001 Bryant Street, San Francisco, CA 94110, USA.
Jaime Hernandez-MaldonadoPendulum Therapeutics, Inc., 2001 Bryant Street, San Francisco, CA 94110, USA.
Andrew ChengPendulum Therapeutics, Inc., 2001 Bryant Street, San Francisco, CA 94110, USA.
Tara KuriharaPendulum Therapeutics, Inc., 2001 Bryant Street, San Francisco, CA 94110, USA.
Jason L BlumProduct Safety Labs, 2394 US Highway 130, Dayton, NJ 08810, USA.
Denise DiCarlo EmeryProduct Safety Labs, 2394 US Highway 130, Dayton, NJ 08810, USA.
Barry LynchIntertek Health Sciences Inc, 2233 Argentia Road, Suite 201, Mississauga, ON L5N 2×7, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A powder formulation of viable

Indexed as

90-day rat studyClostridium beijerinckiigenotoxicitymutagenicityNOAEL

Identifiers

PMID41727408
PMCPMC12918226

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.